Yuntao Xie

发表

Characteristic sequence motifs located at the genomic breakpoints of the translocation t(X;18) in synovial sarcomas

Yong-kun Wei, Menghong Sun, G. Nilsson, 2003, Oncogene.

SYT-SSX is critical for cyclin D1 expression in synovial sarcoma cells: a gain of function of the t(X;18)(p11.2;q11.2) translocation.

G. Nilsson, Yuntao Xie, O. Larsson, 2002, Cancer research.

The SYT-SSX1 fusion type of synovial sarcoma is associated with increased expression of cyclin A and D1. A link between t(X;18)(p11.2; q11.2) and the cell cycle machinery

G. Nilsson, Yuntao Xie, O. Larsson, 2002, Oncogene.

Down‐regulation of the cavin family proteins in breast cancer

Yuntao Xie, Miao Wang, Y. Cong, 2012, Journal of cellular biochemistry.

BRCA1 promoter methylation associated with poor survival in Chinese patients with sporadic breast cancer

Yuntao Xie, D. Deng, X. Wen, 2009, Cancer science.

Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy.

Yuntao Xie, Z. Fan, Jin-feng Li, 2013, Breast.

Protein phosphatase PP6 is required for homology-directed repair of DNA double-strand breaks

Yuntao Xie, J. Stark, Xin Liu, 2011, Cell cycle.

Differential roles of SS18-SSX fusion gene and insulin-like growth factor-1 receptor in synovial sarcoma cell growth.

Yuntao Xie, M. Törnkvist, M. Axelson, 2008, Biochemical and biophysical research communications.

BRCA1 c.5470_5477del, a founder mutation in Chinese Han breast cancer patients

Yuntao Xie, Ye Xu, Z. Fan, 2020, International journal of cancer.

Impact of dose-dense neoadjuvant chemotherapy on pathologic response and survival for HER2-positive breast cancer patients who receive trastuzumab

Yuntao Xie, Z. Fan, Jin-feng Li, 2021, NPJ breast cancer.

Effect of p53 codon 72 genotype on breast cancer survival depends on p53 gene status

Yuntao Xie, Youyong Lu, Ye Xu, 2008, International journal of cancer.

The association of CYP2D6 *10 polymorphism with breast cancer risk and clinico-pathologic characteristics in Chinese women

Yuntao Xie, Ji‐you Li, Ye Xu, 2006, Acta oncologica.

RAD50 germline mutations are associated with poor survival in BRCA1/2–negative breast cancer patients

Yuntao Xie, Z. Fan, Jin-feng Li, 2018, International journal of cancer.

Association of SIPA1 545 C > T polymorphism with survival in Chinese women with metastatic breast cancer

Yuntao Xie, Ye Xu, Z. Fan, 2013, Frontiers of Medicine.

Predictors of sentinel lymph node metastasis in Chinese women with clinical T1-T2 N0 breast cancer and a normal axillary ultrasound

Yuntao Xie, Chun Zhang, Fenfen Fu, 2021, Acta radiologica.

Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers in a large cohort of unselected Chinese breast cancer patients

Yuntao Xie, Ye Xu, Z. Fan, 2020, International journal of cancer.

Germline mutation in DNA‐repair genes is associated with poor survival in BRCA1/2‐negative breast cancer patients

Yuntao Xie, L. Hu, Ye Xu, 2019, Cancer science.

Identification and analysis of CHEK2 germline mutations in Chinese BRCA1/2-negative breast cancer patients

Yuntao Xie, Ye Xu, Z. Fan, 2018, Breast Cancer Research and Treatment.

Circulating DNA of HOTAIR in serum is a novel biomarker for breast cancer

Lei Zhang, Huiqing Cao, Yuntao Xie, 2015, Breast Cancer Research and Treatment.

The risk variant rs11836367 contributes to breast cancer onset and metastasis by attenuating Wnt signaling via regulating NTN4 expression

E. Ziv, Yuntao Xie, Yin Shen, 2022, Science advances.

Somatic mutations in the BRCA1 gene in Chinese women with sporadic breast cancer

Yuntao Xie, Ye Xu, Min Zhang, 2012, Breast Cancer Research and Treatment.

Incidence of BRCA1 somatic mutations and response to neoadjuvant chemotherapy in Chinese women with triple-negative breast cancer.

Yuntao Xie, Z. Fan, Jin-feng Li, 2016, Gene.

Effect of Trastuzumab among HER2-Positive Breast Cancer Patients that Achieved Pathologic Complete Response after Neoadjuvant Chemotherapy

Yuntao Xie, Z. Fan, Jin-feng Li, 2019, Breast Care.

Neuronal protein synuclein γ predicts poor clinical outcome in breast cancer

Yuntao Xie, C. Shou, D. Budman, 2007 .

Ultrasound as a replacement for physical examination in clinical staging of axillary lymph nodes in breast cancer patients

Yuntao Xie, Xiao-Ting Li, Z. Fan, 2019, Thoracic cancer.

Clinical relevance of pathogenic germline variants in mismatch repair genes in Chinese breast cancer patients

Yuntao Xie, L. Hu, Ye Xu, 2022, NPJ breast cancer.

A recurrent CHEK2 p.H371Y mutation is associated with breast cancer risk in Chinese women

Yuntao Xie, Xingzhi Xu, Dongyun Liu, 2011, Human mutation.

Ovarian cancer risk of Chinese women with BRCA1/2 germline pathogenic variants

Yuntao Xie, L. Hu, Ye Xu, 2022, Journal of Human Genetics.

99mTc-rituximab as a tracer for sentinel lymph node biopsy in breast cancer patients: a single-center analysis

Yuntao Xie, Z. Fan, Jin-feng Li, 2018, Breast Cancer Research and Treatment.

Prevalence of BRCA1 and BRCA2 pathogenic variants in 8627 unselected patients with breast cancer: stratification of age at diagnosis, family history and molecular subtype

Xu, Yuntao Xie, L. Hu, 2022, Breast Cancer Research and Treatment.

Impact of the addition of carboplatin to anthracycline‐taxane‐based neoadjuvant chemotherapy on survival in BRCA1/2‐mutated triple‐negative breast cancer

Yuntao Xie, Yi-qiang Liu, Z. Fan, 2020, International journal of cancer.

CACA Guidelines for Holistic Integrative Management of Breast Cancer

Jian Liu, Yuntao Xie, Jin-hai Tang, 2022, Holistic Integrative Oncology.

Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas

Yuntao Xie, O. Larsson, C. Larsson, 2002, Oncogene.

Gene expression profile by blocking the SYT-SSX fusion gene in synovial sarcoma cells. Identification of XRCC4 as a putative SYT-SSX target gene

G. Nilsson, Yuntao Xie, O. Larsson, 2003, Oncogene.

Neoadjuvant endocrine therapy for strongly hormone receptor-positive and HER2-negative early breast cancer: results of a prospective multi-center study

Yuntao Xie, Tao Wang, Zefei Jiang, 2022, Breast Cancer Research and Treatment.

Expression of ER- 36, a Novel Variant of Estrogen Receptor , and Resistance to Tamoxifen Treatment in Breast Cancer

Yuntao Xie, B. Dong, Z. Fan, 2009 .

RAD51C germline mutations in Chinese women with familial breast cancer

Yuntao Xie, Z. Fan, Jin-feng Li, 2011, Breast Cancer Research and Treatment.

Risk of ipsilateral breast tumor recurrence and contralateral breast cancer in patients with and without TP53 variant in a large series of breast cancer patients

Yuntao Xie, Z. Fan, Jin-feng Li, 2022, Breast.

Clinical phenotypes combined with saturation genome editing identifying the pathogenicity of BRCA1 variants of uncertain significance in breast cancer

Yuntao Xie, L. Hu, Ye Xu, 2020, Familial Cancer.

Comprehensive analysis of BRCA1 and BRCA2 germline mutations in a large cohort of 5931 Chinese women with breast cancer

Yuntao Xie, Z. Fan, Jin-feng Li, 2016, Breast Cancer Research and Treatment.

Single-Cell RNA Sequencing Reveals the Cellular Origin and Evolution of Breast Cancer in BRCA1 Mutation Carriers

Yuntao Xie, L. Hu, Z. Fan, 2021, Cancer Research.

HER2 somatic mutations are associated with poor survival in HER2‐negative breast cancers

Tianfeng Wang, Yuntao Xie, Yuntao Xie, 2017, Cancer science.

TP53 mutations are associated with higher rates of pathologic complete response to anthracycline/cyclophosphamide‐based neoadjuvant chemotherapy in operable primary breast cancer

Yuntao Xie, Ye Xu, Z. Fan, 2016, International journal of cancer.

Mutations in RECQL Gene Are Associated with Predisposition to Breast Cancer

Yuntao Xie, H. Lou, Yisui Xia, 2015, PLoS genetics.

Risk of ipsilateral breast tumor recurrence in primary invasive breast cancer following breast-conserving surgery with BRCA1 and BRCA2 mutation in China

Yuntao Xie, W. Cao, Z. Fan, 2019, Breast Cancer Research and Treatment.

miR-127 Regulates Cell Proliferation and Senescence by Targeting BCL6

Yuntao Xie, Miao Wang, Y. Cong, 2013, PloS one.

Establishment of a network-based intra-hospital virtual cancer biobank.

Yuntao Xie, J. Ji, Lianhai Zhang, 2015, Biopreservation and Biobanking.

Expression of ER-{alpha}36, a novel variant of estrogen receptor {alpha}, and resistance to tamoxifen treatment in breast cancer.

Yuntao Xie, Zhaoyi Wang, B. Dong, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer

Yuntao Xie, Z. Fan, Jin-feng Li, 2012, Breast Cancer Research and Treatment.

Predictive value of BRCA1/2 mRNA expression for response to neoadjuvant chemotherapy in BRCA‐negative breast cancers

Yuntao Xie, Ye Xu, Z. Fan, 2017, Cancer science.

Association between HER2 status and response to neoadjuvant anthracycline followed by paclitaxel plus carboplatin chemotherapy without trastuzumab in breast cancer.

Yuntao Xie, Yi-qiang Liu, Z. Fan, 2015, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

Association of PIK3CA Mutation Status before and after Neoadjuvant Chemotherapy with Response to Chemotherapy in Women with Breast Cancer

Yuntao Xie, Yi-qiang Liu, Z. Fan, 2015, Clinical Cancer Research.

Association of PIK 3 CA Mutation Status before and after Neoadjuvant Chemotherapy with Response to Chemotherapy in Women with Breast Cancer

Yuntao Xie, Yi-qiang Liu, Z. Fan, 2015 .

A novel high-throughput assay using mixed genomic DNA for fast screening germline pathogenic variants in breast cancer susceptibility genes

Yuntao Xie, L. Hu, Ye Xu, 2021, bioRxiv.

HER2 Pro1170Ala polymorphism is associated with decreased survival rate in HER2-negative breast cancer.

Yuntao Xie, Ye Xu, P. Si, 2017, Oncology letters.

Prevalence of BRCA 1 / 2 large genomic rearrangements in Chinese women with sporadic triple-negative or familial breast cancer Running title : BRCA 1 / 2 large genomic rearrangements in Chinese women with breast cancer

Yuntao Xie, Tianfeng, Z. Fan, 2018 .

A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer

Deyao Zhao, Lei Zhang, Xingyu Jin, 2015, Breast Cancer Research and Treatment.

Association between p53 codon 72 polymorphism and curative ef- fect of postoperative chemo-radiotherapy for breast cancer

Yuntao Xie, Ye Xu, G. Zhu, 2015 .

p53 Codon 72 Polymorphism Predicts the Pathologic Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer

Yuntao Xie, Youyong Lu, Ye Xu, 2005, Clinical Cancer Research.

p 53 Codon 72 Polymorphism Predicts the Pathologic Response to Neoadjuvant Chemotherapy in Patientswith Breast Cancer

Yuntao Xie, Youyong Lu, Ye Xu, 2005 .

Prevalence and characterization of ATM germline mutations in Chinese BRCA1/2-negative breast cancer patients

Yuntao Xie, Z. Fan, Jin-feng Li, 2019, Breast Cancer Research and Treatment.

Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients

Yuntao Xie, Z. Fan, Jin-feng Li, 2017, Clinical Cancer Research.

Association between CHEK2 H371Y mutation and response to neoadjuvant chemotherapy in women with breast cancer

Yuntao Xie, Ye Xu, Z. Fan, 2015, BMC Cancer.

Impact of dose-dense neoadjuvant chemotherapy on pathologic response and survival for HER2-positive breast cancer patients who receive trastuzumab

Yuntao Xie, Z. Fan, Jin-feng Li, 2021, npj Breast Cancer.

Efficacy of pegfilgrastim to support neoadjuvant dose-dense epirubicin and cyclophosphamide chemotherapy in breast cancer

Yuntao Xie, Z. Fan, Jin-feng Li, 2019, Supportive Care in Cancer.

Cancer risk in relatives of BRCA1/2 pathogenic variant carriers in a large series of unselected patients with breast cancer

Yuntao Xie, L. Hu, Ye Xu, 2023, Cancer biology & medicine.

Efficacy of physical examination, ultrasound, and ultrasound combined with fine-needle aspiration for axilla staging of primary breast cancer

Yuntao Xie, W. Cao, Rui Huang, 2015, Breast Cancer Research and Treatment.

BRCA-CRisk: A Contralateral Breast Cancer Risk Prediction Model for BRCA Carriers

Yuntao Xie, L. Hu, Ye Xu, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Feasibility of using negative ultrasonography results of axillary lymph nodes to predict sentinel lymph node metastasis in breast cancer patients

Yuntao Xie, Z. Fan, Jin-feng Li, 2018, Cancer medicine.

KLHL22 activates amino-acid-dependent mTORC1 signalling to promote tumorigenesis and ageing

Yuntao Xie, Y. Liu, Wen Li, 2018, Nature.

Comparison of Survival After Breast-Conserving Therapy vs Mastectomy Among Patients With or Without the BRCA1/2 Variant in a Large Series of Unselected Chinese Patients With Breast Cancer

Yuntao Xie, Z. Fan, Jin-feng Li, 2021, JAMA network open.

Low Expression of PALB2 is Associated With Poor Survival in Chinese Women With Primary Breast Cancer.

Yuntao Xie, Ye Xu, L. Yao, 2023, Clinical breast cancer.

A genome-wide association study identifies WT1 variant with better response to 5-fluorouracil, pirarubicin and cyclophosphamide neoadjuvant chemotherapy in breast cancer patients

Yuntao Xie, C. Yin, Hong Zhang, 2015, Oncotarget.

Association of p73 G4C14-to-A4T14 (GC/AT) polymorphism with breast cancer survival.

Yuntao Xie, B. Dong, L. Yao, 2006, Carcinogenesis.

Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations

Yuntao Xie, Z. Fan, Jin-feng Li, 2016, Breast Cancer Research and Treatment.

Association between 15 known or potential breast cancer susceptibility genes and breast cancer risks in Chinese women

Yuntao Xie, S. Sundaram, L. Hu, 2021, Cancer biology & medicine.

Interpretation of specification for breast cancer screening, early diagnosis, and treatment management in Chinese women

Yuntao Xie, Anhua Li, Yong Wang, 2021, Journal of the National Cancer Center.

Association between HER2 germline mutation A270S and prognosis in patients with primary breast cancer.

Yuntao Xie, Ye Xu, P. Si, 2018, Cancer biomarkers : section A of Disease markers.

Spectrum and clinical relevance of PALB2 germline mutations in 7657 Chinese BRCA1/2-negative breast cancer patients

Yuntao Xie, Yifan Wu, Ye Xu, 2019, Breast Cancer Research and Treatment.

Early prediction of pathological outcomes to neoadjuvant chemotherapy in breast cancer patients using automated breast ultrasound

Yuntao Xie, Z. Fan, Jin-feng Li, 2016, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

Functional analysis of BRCT missense mutations in BRCA1-mutated Chinese Han familial breast cancer

Yuntao Xie, C. Yin, Xi Ma, 2017, Oncology letters.

Breast-conserving therapy and modified radical mastectomy for primary breast carcinoma: a matched comparative study.

Yuntao Xie, Z. Fan, Jin-feng Li, 2015, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

Clinical relevance of pathogenic germline variants in mismatch repair genes in Chinese breast cancer patients

Yuntao Xie, L. Hu, Ye Xu, 2022, npj Breast Cancer.

Inhibition of STAT5a by Naa10p contributes to decreased breast cancer metastasis.

Yuntao Xie, Yan Zeng, C. Shou, 2014, Carcinogenesis.

Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status

Yuntao Xie, O. Larsson, Youyong Lu, 2006, Breast Cancer Research and Treatment.

Combination impact of axillary lymph node status and biological subtypes on prognosis and breast conserving surgery in locally-invasive breast cancer : a real-world study of a Chinese population

Yuntao Xie, Z. Fan, Jin-feng Li, 2019 .

Impact of multifocal or multicentric disease on local recurrence and survival in breast cancer patients with or without BRCA1/2 variants

Yuntao Xie, L. Hu, Ye Xu, 2023, Breast Cancer Research and Treatment.

Impact of clinical and pathological factors on local recurrence after breast-conserving treatment: CT-based localization for a tumor bed boost yielded better local control when compared with a surgical scar

Yuntao Xie, Z. Fan, Jin-feng Li, 2019, Journal of Cancer.

Low expression of RECQL is associated with poor prognosis in Chinese breast cancer patients

Yuntao Xie, Ye Xu, Z. Fan, 2018, BMC Cancer.

Value of pre-treatment biomarkers in prediction of response to neoadjuvant endocrine therapy for hormone receptor-positive postmenopausal breast cancer.

Yuntao Xie, B. Dong, Jin-feng Li, 2013, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

Replication stress inducing ELF3 upregulation promotes BRCA1-deficient breast tumorigenesis in luminal progenitors

Yuntao Xie, L. Hu, Jiadong Wang, 2023, bioRxiv.

Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer.

Yuntao Xie, C. Shou, D. Budman, 2007, International journal of cancer.

Prevalence and Clinical Implications of BRCA 1 / 2 Germline Mutations in Chinese Women with Breast Cancer

Yuntao Xie, 2017 .

Peking University - Juntendo University Joint Symposium on Cancer Research and Treatment: Prevalence and Clinical Implications of BRCA1/2 Germline Mutations in Chinese Women with Breast Cancer

Yuntao Xie, 2017 .

Comparisons of breast conserving therapy versus mastectomy in young and old women with early-stage breast cancer: long-term results using propensity score adjustment method

Yuntao Xie, Z. Fan, Jin-feng Li, 2020, Breast Cancer Research and Treatment.

BRCA1 germline mutations and tumor characteristics in Chinese women with familial or early-onset breast cancer

Yuntao Xie, Youyong Lu, K. Pan, 2009, Breast Cancer Research and Treatment.

Increased expression of insulin-like growth factor I receptor in malignant cells expressing aberrant p53: functional impact.

G. Nilsson, Yuntao Xie, O. Larsson, 2000, Cancer research.

Low expression of RECQL is associated with poor prognosis in Chinese breast cancer patients

Yuntao Xie, Ye Xu, Z. Fan, 2018, BMC Cancer.

Establishment of a network-based intra-hospital virtual cancer biobank.

Yuntao Xie, J. Ji, Lianhai Zhang, 2015, Biopreservation and biobanking.

Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy.

Yuntao Xie, Z. Fan, Jin-feng Li, 2013, Breast.